TM-T1089 - Etomidate (33125-97-2)
Sorry, no product with reference TM-T1089has been found, but please check out the following similar products:
See more
Etomidate
CAS:33125-97-2
Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoi
Formula:
C14H16N2O2
Color and Shape:
White Off-White Powder
Molecular weight:
244.12118
Estimated delivery in United States, on Thursday 2 May 2024
Ref: 4Z-E-076014
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Friday 3 May 2024
Etomidate
CAS:33125-97-2
Formula:
C14H16N2O2
Purity:
≥ 98.0%
Color and Shape:
White solid
Molecular weight:
244.29
Ref: 7W-GL9418
| Undefined size | To inquire |
Estimated delivery in United States, on Friday 3 May 2024
Etomidate
CAS:33125-97-2
Formula:
C14H16N2O2
Purity:
>98.0%(GC)
Color and Shape:
White to Almost white powder to crystal
Molecular weight:
244.29
Ref: 3B-E0897
| 100mg | 83.00 € | |
| 500mg | 249.00 € |
Estimated delivery in United States, on Tuesday 7 May 2024
Ref: 86-MM1264.00
| 100mg | 1,075.00 € |
Estimated delivery in United States, on Tuesday 7 May 2024
Etomidate
Controlled ProductCAS:33125-97-2
Applications Etomidate is a hypnotic. Neuroprotective & Neuroresearch Products Not a dangerous good if item …
Formula:
C14H16N2O2
Color and Shape:
Off-White
Molecular weight:
244.29
Ref: TR-E933300
| 10mg | 121.00 € | |
| 25mg | 227.00 € | |
| 50mg | 351.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
Etomidate
Controlled ProductCAS:33125-97-2
Etomidate is a potent, non-competitive, centrally acting α-adrenergic receptor agonist that has been used as …
Formula:
C14H16N2O2
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
244.29 g/mol
Ref: 3D-FE23198
| 25mg | 84.00 € | |
| 50mg | 124.00 € | |
| 100mg | 179.00 € | |
| 250mg | 336.00 € | |
| 500mg | 448.00 € |
Estimated delivery in United States, on Monday 13 May 2024
Ref: 41-E2503000
| 50mg | 115.00 € |
Estimated delivery in United States, on Tuesday 30 Apr 2024
